1. Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high‐risk MDS. (16th November 2015) Authors: Mawad, Raya; Becker, Pamela S.; Hendrie, Paul; Scott, Bart; Wood, Brent L.; Dean, Carol; Sandhu, Vicky; Deeg, Hans Joachim; Walter, Roland; Wang, Lixia; Myint, Han; Singer, Jack W.; Estey, Elihu; Pagel, John M. Journal: British journal of haematology Issue: Volume 172:Number 2(2016) Page Start: 238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗